Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.

The voltage activated K+ channel (Kv1.3) has recently been identified as the molecule that sets the resting membrane potential of peripheral human T lymphoid cells. In vitro studies indicate that blockage of Kv1.3 inhibits T cell activation, suggesting that Kv1.3 may be a target for immunosuppression. However, despite the in vitro evidence, there has been no in vivo demonstration that blockade of Kv1.3 will attenuate an immune response. The difficulty is due to species differences, as the channel does not set the membrane potential in rodent peripheral T cells. In this study, we show that the channel is present on peripheral T cells of miniswine. Using the peptidyl Kv1.3 inhibitor, margatoxin, we demonstrate that Kv1.3 also regulates the resting membrane potential, and that blockade of Kv1.3 inhibits, in vivo, both a delayed-type hypersensitivity reaction and an Ab response to an allogeneic challenge. In addition, prolonged Kv1.3 blockade causes reduced thymic cellularity and inhibits the thymic development of T cell subsets. These results provide in vivo evidence that Kv1.3 is a novel target for immunomodulation.

• Publication year

  1997

• Venue

  Journal of Immunology

• Publication date

  1997-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.158.11.5120PMID 9164927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic and other effects on antibody and cell mediated immune response in swine leucocyte antigen (SLA)-defined miniature pigs.

  2009cited by this paper
• Potassium and calcium channels in lymphocytes.

  1995cited by this paper
• Identification of Kv1.1 Expression by Murine CD4−CD8− Thymocytes

  1995cited by this paper
• Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.

  1994cited by this paper
• Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation

  1993cited by this paper
• Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels.

  1993cited by this paper
• Anti-CD3-stimulated Ca2+ signal in individual human peripheral T cells. Activation correlates with a sustained increase in intracellular Ca2+1.

  1993cited by this paper
• Lack of voltage sensitive potassium channels and generation of membrane potential by sodium potassium ATPase in murine T lymphocytes.

  1993cited by this paper
• Characterization and Functional Expression of Genomic DNA Encoding the Human Lymphocyte Type n Potassium Channel

  1992cited by this paper
• Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.

  1992cited by this paper
• INDUCTION OF SPECIFIC TOLERANCE TO CLASS I‐DISPARATE RENAL ALLOGRAFTS IN MINIATURE SWINE WITH CYCLOSPORINE

  1992cited by this paper
• Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

  1992cited by this paper
• Simplified gene nomenclature

  1991cited by this paper
• FETAL PANCREAS TRANSPLANTATION IN MINIATURE SWINE: IV. SUPPRESSION OF DTH AND MLR RESPONSES BY TREATMENT WITH ULTRAVIOLET LIGHT‐IRRADIATED PERIPHERAL BLOOD LYMPHOCYTES

  1990cited by this paper
• IN VIVO TREATMENT WITH ANTIPORCINE T CELL ANTIBODIES

  1990cited by this paper
• Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.

  1989cited by this paper
• Blocking of human T lymphocyte activation by channel antagonists

  1989cited by this paper
• The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

  1986cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper

• Voltage-gated potassium channels (Kv) in GtoPdb v.2025.4

  2025cites this paper
• Molecular Basis of Ionic Suppression of ZAP-70 Dependent T Cell Receptor Activation

  2025cites this paper
• Voltage-gated potassium channels (Kv) in GtoPdb v.2025.3

  2025cites this paper
• Neurocardiac pathologies associated with potassium channelopathies

  2024cites this paper
• Current Status of Peptide Medications and the Position of Active Therapeutic Peptides with Scorpion Venom Origin

  2023cites this paper
• Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment

  2023influential citation
• Transcriptome‐wide summary data‐based Mendelian randomization analysis reveals 38 novel genes associated with severe COVID‐19

  2022cites this paper
• Accelerating topical formulation development for inflammatory dermatoses; an ex vivo human skin culture model consistent with clinical therapeutics.

  2022cites this paper
• POTENTIAL OF SCORPION VENOM FOR THE TREATMENT OF VARIOUS DISEASES

  2022cites this paper
• GFP–Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers

  2022cites this paper
• Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators

  2022cites this paper
• Mass spectrometry‐based top‐down and bottom‐up approaches for proteomic analysis of the Moroccan Buthus occitanus scorpion venom

  2021cites this paper
• The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation

  2021cites this paper
• Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis

  2021cites this paper
• Purlisin, a toxin‐like defensin derived from clinical pathogenic fungus Purpureocillium lilacinum with both antimicrobial and potassium channel inhibitory activities

  2020cites this paper
• Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds

  2020cites this paper
• Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.

  2020cites this paper
• New opportunities and challenges of venom-based and bacteria-derived molecules for anticancer targeted therapy.

  2020cites this paper
• Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4‐mediated calcium entry in microglia

  2020cites this paper
• Genetic analysis of IgG4-related disease

  2020cites this paper
• The binding process of BmKTX and BmKTX-D33H toward to Kv1.3 channel: a molecular dynamics simulation study

  2020cites this paper
• PPLK+C: A Bioinformatics Tool for Predicting Peptide Ligands of Potassium Channels Based on Primary Structure Information

  2020cites this paper
• Fighting rheumatoid arthritis: Kv1.3 as a therapeutic target.

  2019cites this paper
• Fritillariae Thunbergii Bulbus: Traditional Uses, Phytochemistry, Pharmacodynamics, Pharmacokinetics and Toxicity

  2019cites this paper
• Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression

  2019cites this paper
• Voltage-gated potassium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• TRP channels and a dextran sulfate activated rise in intracellular Ca2+ and Na+ in a subpopulation of double positive thymocytes

  2019cites this paper
• The secret life of ion channels: Kv1.3 potassium channels and proliferation.

  2018cites this paper
• Immune effects of the neurotoxins ciguatoxins and brevetoxins

  2018cites this paper
• Highly Sensitive and Selective Potassium Ion Detection Based on Graphene Hall Effect Biosensors

  2018cites this paper
• Ion channels as therapeutic antibody targets

  2018cites this paper
• Amendment history : Erratum ( July 2003 ) The voltage-gated Kv 1 . 3 K + channel in effector memory T cells as new target for MS

  2018cites this paper
• A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3

  2018cites this paper
• Channels in Human Mast Cells Resting and Activation-Dependent Ion

  2017cites this paper
• of the Voltage-Gated Potassium Channel Characterization of the Functional Properties

  2017cites this paper
• Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit

  2017cites this paper
• The functional role of Ca-and voltage-gated potassium channels in activated human T cells and fibroblast-like synoviocytes

  2017cites this paper
• Venom‐derived peptide inhibitors of voltage‐gated potassium channels

  2017cites this paper
• Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease.

  2017cites this paper
• Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells

  2017cites this paper
• GABAA receptor α4-subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model.

  2017cites this paper
• The secret life of ion channels : Kv 1 . 3 potassium channels and 1 proliferation 2

  2017cites this paper
• Peptide therapeutics from venom: Current status and potential.

  2017cites this paper
• Margatoxin ( MgTX ) and Its Effect on Immune Response and Disease Development

  2016cites this paper
• Normal human CD4+ helper T cells express Kv1.1 voltage-gated K+ channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway

  2016cites this paper
• Effet de la stimulation du TLR2 et de la sécrétion d'acétate sur la susceptibilité à l'infection au VIH-1 des lymphocytes T CD4+ primaires

  2016cites this paper
• Peimine, a main active ingredient of Fritillaria, exhibits anti-inflammatory and pain suppression properties at the cellular level.

  2016cites this paper
• Scorpion Toxin Polyptides as Therapeutic Agents: An Overview.

  2016cites this paper
• Efficient enzymatic cyclization of an inhibitory cystine knot‐containing peptide

  2016cites this paper
• Kv1.3 inhibitors in the treatment of glioma and melanoma

  2015cites this paper
• Epicardial Adipose Tissue Has a Unique Transcriptome that is Modified in Severe Coronary Artery Disease

  2015cites this paper
• Targeting ion channels for cancer therapy by repurposing the approved drugs.

  2015cites this paper
• Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins

  2015cites this paper
• Ion channels in innate and adaptive immunity.

  2015cites this paper
• Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention

  2015cites this paper
• Therapeutic use of scorpion venom

  2014cites this paper
• HIF-1α–Mediated Upregulation of TASK-2 K+ Channels Augments Ca2+ Signaling in Mouse B Cells under Hypoxia

  2014cites this paper
• Electrophysiological Characterization of Ts6 and Ts7, K+ Channel Toxins Isolated through an Improved Tityus serrulatus Venom Purification Procedure

  2014cites this paper
• Ion Channels in Peripheral Blood Mononuclear Cells– Effect of Culture and Ascorbic Acid.

  2014cites this paper
• , Potency , Selectivity , and Half-life Scorpion Venom Peptides Engineered for Targeting the Ion Channel Kv 1 . 3 with Membrane Biology

  2014cites this paper
• Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.

  2014cites this paper
• Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life

  2014cites this paper
• Scorpion venom components as potential candidates for drug development

  2014cites this paper
• T CELL SUBSETS AND DISEASE MECHANISMS IN INFLAMMATORY MYOPATHIES

  2014cites this paper
• Isolation, oxidative folding and ion-channel modulation of plant cyclotides

  2013influential citation
• Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation – a pilot study

  2013cites this paper
• Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL[S]

  2013cites this paper
• Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state.

  2013cites this paper
• Effect of the Kv1.3 voltage-gated potassium channel blocker PAP-1 on the initiation and progress of atherosclerosis in a rat model

  2013cites this paper
• Autoimmune Encephalomyelitis and Inhibits Channels Improves Experimental Selective Blocking of Voltage-Gated K+

  2013cites this paper
• Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes

  2013cites this paper
• Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.

  2012cites this paper
• Potassium channel expression and function in the N9 murine microglial cell line

  2012cites this paper
• Mechanism of Electromechanical Coupling in Voltage-Gated Potassium Channels

  2012cites this paper
• Potassium Channels in T Lymphocytes

  2012cites this paper
• Regulation of K+ Channels by Cholesterol-Rich Membrane Domains in the Immune System

  2012cites this paper
• Structural changes of the outer and inner vestibule of hKv1.3 channels during C type inactivation

  2012cites this paper
• Neuropathophysiological Effect and Immuno-Inflammatory Response Induced by Kaliotoxin of Androctonus Scorpion Venom

  2012cites this paper
• Modulation of T cell activation by localized K⁺ accumulation at the immunological synapse--a mathematical model.

  2012cites this paper
• Increase in voltage gated potassium currents of human lymphocytes on culture.

  2012cites this paper
• Detailed examination of Mg 2 + and pH sensitivity of human TRPM 7 1 channels

  2012cites this paper
• Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

  2012influential citation
• Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease

  2012cites this paper
• Detailed examination of Mg2+ and pH sensitivity of human TRPM7 channels.

  2012cites this paper
• Polymorphism in the KCNA3 Gene Is Associated with Susceptibility to Autoimmune Pancreatitis in the Japanese Population

  2011cites this paper
• Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo.

  2011cites this paper
• Ion channels in autoimmune neurodegeneration

  2011cites this paper
• The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression

  2011cites this paper
• A C-terminal PDZ binding domain modulates the function and localization of Kv1.3 channels.

  2011cites this paper
• CENTER FOR DRUG EVALUATION AND RESEARCH

  2010cites this paper
• From the Background to the Spotlight: TASK Channels in Pathological Conditions

  2010cites this paper
• SUBCELLULAR DISTRIBUTION OF A VOLTAGE-GATED POTASSIUM CHANNEL: THE EFFECT OF LOCALIZATION ON CHANNEL FUNCTION

  2010cites this paper
• Kv1.3: The perfect opening of the platelet voltage gate

  2010cites this paper
• Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.

  2010cites this paper
• Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy

  2010cites this paper
• Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

  2010cites this paper
• Voltage-gated potassium channels as therapeutic targets

  2009cites this paper
• Recombinant Kv Channels at the Membrane of Escherichia coli Bind Specifically Agitoxin2

  2009cites this paper
• Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.

  2009cites this paper
• Kv1.3potassiumchannelsasa therapeutictargetinmultiple sclerosis

  2009cites this paper